Clinical trials: Marijuana Usage
Alcohol Drinking, Cannabis Use
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
The goal of this treatment development project is to develop an adaptive ecological momentary intervention (a-EMI) for young adults using marijuana and alcohol that is grounded in self-regulation and social cognitive theories.
- Trial name
- SAFERR (NCT05991882)
- Testing
- Condition 1: Craving daily+PBS daily, Condition 2: Craving daily+PBS trigger, Condition 3: Craving trigger+PBS daily
- Where
- United States
- Volunteers
- 128 people
- Sponsor
- Kaiser Permanente
Psychotic Disorders, Cannabis Use Disorder
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
The goal of this clinical trial is to conduct a single-blind randomized controlled trial to verify whether the Avatar Intervention has greater efficacy over supportive intervention to reduce cannabis use in patients with…
- Conditions
- Psychotic Disorders, Cannabis Use Disorder, Mental Health Disorder
- Trial name
- AC2 (NCT05704582)
- Testing
- Avatar Intervention, Addiction supportive intervention
- Where
- Canada
- Volunteers
- 150 people
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
Opioid Use Disorder
Reducing Pain and Opioid Use With CBD
This is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to reduce opioid use, anxiety, and pain and improve sleep and…
- Trial name
- NCT05299944
- Testing
- Cannabidiol
- Where
- 2 sites in United States
- Volunteers
- 126 people
- Sponsor
- University of Colorado, Denver
Repetitive Transcranial Magnetic Stimulation (rTMS), Schizophrenia
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia
The high prevalence of cannabis and other substance use disorders are a major barrier to recovery in people with schizophrenia. Moreover, schizophrenia patients have significant deficits in cognitive function, which may be…
- Conditions
- Repetitive Transcranial Magnetic Stimulation (rTMS), Schizophrenia, Cannabis Use Disorder, Cognition
- Trial name
- rTMSCANSZ (NCT03189810)
- Testing
- Repetitive Transcranial Magnetic Stimulation (rTMS), Weekly Counselling Session
- Where
- Canada
- Volunteers
- 24 people
- Sponsor
- Centre for Addiction and Mental Health
Cannabis Use
Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users.
- Trial name
- NCT07513337
- Testing
- Strain label, Claim
- Where
- United States
- Volunteers
- 3,035 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
Youth With HIV
Consequences of Marijuana Use in HIV-infected Youth
Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, [including substance use and frequency], and…
- Trial name
- NCT03927053
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Duke University
Cannabis Use Disorder, Mental Health Disorder
Regulated Cannabis Access in Basel
The randomised controlled study on regulated cannabis access in pharmacies in Basel aims to investigate the effects of regulated cannabis access on consumption behaviour and mental and physical health in comparison to the illegal…
- Conditions
- Cannabis Use Disorder, Mental Health Disorder, Physical Illness
- Trial name
- NCT05522205
- Testing
- Regulated cannabis access in pharmacies
- Where
- Switzerland
- Volunteers
- 374 people, healthy volunteers welcome
- Sponsor
- Health Department of the Canton of Basel-Stadt
Cannabis Use Disorder
Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing
The goal of this clinical trial is to learn how adding brain stimulation to a brief counseling session affects adults with cannabis use disorder.
- Trial name
- NCT07787572
- Testing
- transcranial alternating current stimulation, Motivational interviewing (MI)
- Where
- United States
- Volunteers
- 82 people
- Sponsor
- The Mind Research Network
Insomnia, Alcohol Use, Unspecified
Research Evaluating Sleep & Trends for Universal Prevention
This study is designed to develop an integrated intervention to reduce alcohol and marijuana use and consequences and improve sleep among young adults with comorbid heavy episodic drinking, marijuana use, and sleep impairment.
- Conditions
- Insomnia, Alcohol Use, Unspecified, Marijuana Use
- Trial name
- REST-UP (NCT04783519)
- Testing
- Brief Behavioral Therapy for Insomnia (BBTI), Brief Alcohol Screening and Intervention for College Students (BASICS)
- Where
- United States
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- University of Washington
Cannabis Use
CanCope: Digital Intervention for Coping With Cannabis Craving
The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.
- Trial name
- NCT05328362
- Testing
- CanCope
- Where
- United States
- Volunteers
- 53 people
- Sponsor
- Trustees of Dartmouth College
Cannabis Use
Impact of Progesterone on Stress Reactivity and Cannabis Use
This is a research study to find out if a hormone called progesterone affects marijuana users' stress response and marijuana use.
- Trial name
- NCT03729869
- Testing
- Progesterone
- Where
- United States
- Volunteers
- 148 people
- Sponsor
- Medical University of South Carolina
Cannabis Use Disorder
Approach Bias Modification for the Treatment of Cannabis Use Disorder
Effective and durable treatments for cannabis use disorder remain elusive. Given the increasing prevalence rates of cannabis use and CUD nationwide, investigation of novel treatments is warranted.
- Trial name
- NCT03629990
- Testing
- Approach Bias Modification (ABM), Psychosocial therapy for cannabis use disorder.
- Where
- United States
- Volunteers
- 104 people
- Sponsor
- Medical University of South Carolina
Pain, Cannabis
Enhancing Medication-based Analgesia in Humans- STUDY 2
This is a single-group, within-subject, double-blind, double-dummy, placebo and active-controlled study evaluated whether the FDA-approved cannabinoid cannabidiol (CBD; Epidiolex) would enhance analgesia, subjective reports, and…
- Conditions
- Pain, Cannabis, Opioid Use
- Trial name
- NCT04036968
- Testing
- Within-subject test of blinded study medications
- Where
- United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins University
Depression, Cannabis Use Disorder
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity…
- Conditions
- Depression, Cannabis Use Disorder, HIV
- Trial name
- NCT05453513
- Testing
- MRI Study
- Where
- United States
- Volunteers
- 280 people
- Sponsor
- University of Miami
Insomnia Disorder
Cannabinol Use in Patients With Insomnia Disorder
This study aims to investigate the acute effects of cannabinol (CBN) 30 mg and 300 mg, versus placebo, on sleep architecture and next-day functioning in adults aged 25-65 years with chronic insomnia disorder.
- Trial name
- CUPID (NCT05344170)
- Testing
- 30 mg Cannabinol (CBN), 300 mg Cannabinol (CBN)
- Where
- Australia
- Volunteers
- 20 people
- Sponsor
- Woolcock Institute of Medical Research
Alcohol Drinking, Cannabis Use
Cannabis' Impact on Alcohol Consumption
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which…
- Conditions
- Alcohol Drinking, Cannabis Use, Cannabis, Alcohol Use Disorder
- Trial name
- NCT05389930
- Testing
- THC-dominant cannabis, CBD-dominant cannabis, Alcohol
- Where
- United States
- Volunteers
- 350 people, healthy volunteers welcome
- Sponsor
- Brown University
Cannabis Use, Major Depressive Disorder
Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression
The prevalence of major depressive disorder (MDD) is ~5.0%, and rates of co-occurring SUDs in these patients approach 40-50%. Specifically, rates of co-morbid cannabis use disorder (CUD) in patients with MDD are elevated 2-3 fold…
- Conditions
- Cannabis Use, Major Depressive Disorder, Cognitive Impairment
- Trial name
- NCT04935619
- Testing
- Contingency Reinforcement, Non-Contingency Reinforcement
- Where
- Canada
- Volunteers
- 52 people
- Sponsor
- Centre for Addiction and Mental Health
Alzheimer Disease
Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease
Brief Summary: The objective of the study is to evaluate the effect of cannabinoids on Alzheimer's Disease. This is a double-blind, randomized, placebo-controlled clinical trial.
- Trial name
- DAZACANN (NCT06570928)
- Testing
- Cannabis
- Where
- Brazil
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Federal University of Latin American Integration
Alzheimer Disease (AD)
Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase
Alzheimer's Disease (AD) has become a significant public health issue due to the increase in its incidence from 2.0 to 16.8 cases per thousand people in a year, based on 2022 data.
- Trial name
- DAZA OPEN (NCT07091747)
- Testing
- Cannabis 50 mg of CBD and 5 mg of THC
- Where
- Brazil
- Volunteers
- 61 people
- Sponsor
- Federal University of Latin American Integration
Cannabis Use
Culturally Tailored Cannabis Use Disorder App
The present study aims to address disparities in cannabis use outcomes among African American/Black (hereby referred to as Black) adults with cannabis use disorder (CUD).
- Trial name
- NCT05566730
- Testing
- CT-MICART App, Control
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Houston